[{"orgOrder":0,"company":"Maastricht University Medical Center","sponsor":"Unilever","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"NETHERLANDS","productType":"Enzyme","year":"2014","type":"Inapplicable","leadProduct":"Flaxseed","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Maastricht University Medical Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Maastricht University Medical Center \/ Unilever","highestDevelopmentStatusID":"1","companyTruncated":"Maastricht University Medical Center \/ Unilever"}]

Find Clinical Drug Pipeline Developments & Deals for Linseed Oil

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Maastricht University Medical Center

                          Country arrow
                          Global ChemShow
                          Not Confirmed

                          Maastricht University Medical Center

                          Country arrow
                          Global ChemShow
                          Not Confirmed

                          Details : Flaxseed Oil is a Enzyme drug candidate, which is currently being evaluated in clinical studies for the treatment of Hypertension.

                          Product Name : Undisclosed

                          Product Type : Enzyme

                          Upfront Cash : Inapplicable

                          September 18, 2014

                          Lead Product(s) : Flaxseed

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Undisclosed

                          Sponsor : Unilever

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank